Elanco (ELAN) CFO Robert VanHimbergen Receives Award

What Happened
Robert VanHimbergen, Executive Vice President and Chief Financial Officer of Elanco Animal Health (ELAN), was granted 8.219 deferred stock units on August 21, 2026. The filing shows a per-unit valuation of $23.97 for an aggregate notional value of about $197. This was an award (transaction code A) in the form of deferred stock units (a derivative), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-08-21. Filing date: 2026-08-25 (filed within the standard 2-business-day window).
• Grant: 8.219 deferred stock units at $23.97 per unit; aggregate value ≈ $197.
• Nature of instrument: Derivative — each deferred stock unit represents the right to receive one share of common stock or the cash equivalent (Footnote F1).
• Settlement: Deferred stock units settle in cash or shares following termination of employment or during a specified future year under the Executive Deferral and Stock Match Plan (Footnote F2).
• Shares owned after transaction: Not specified in this Form 4 filing.
• Transaction code: A = Award/Grant. This is compensation-related, not a market trade.

Context
Deferred stock units are a form of compensation that convert to shares or cash at a later date, so this grant does not immediately change the insider’s market holdings or indicate a near-term buy/sell decision. The dollar value is small (~$197), suggesting a routine compensation credit under the company’s deferral plan rather than a material change in insider ownership.